Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

RTTNews | Před 1178 dny
Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

(RTTNews) - While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2022. The company also issued outlook for the third quarter.

For fiscal 2022, the company continues to project adjusted earnings in a range of $3.21 to $3.29 per share on revenues between $1.557 billion and $1.575 billion, with organic revenue growth of 4.0 to 5.2 percent, based on better than expected first half performance.

Previously, the company expected adjusted earnings in a range of $3.27 to $3.35 per share on revenues between $1.58 billion and $1.60 billion, with organic revenue growth of 3.8 to 5.2 percent.

On average, 11 analysts polled by Thomson Reuters expect the company to report earnings of $3.31 per share on revenues of $1.59 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company expects adjusted earnings in a range of $0.78 to $0.82 per share on revenues between $383 million and $391 million, with organic revenue growth of 2.6 to 4.8 percent.

The Street is looking for earnings of $0.84 per share on revenues of $398.66 million for the quarter.

For the second quarter, the Company reported net income of $44.79 million or $0.54 per share, up from $35.07 million or $0.41 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter was $0.82 per share, compared to $0.79 per share in the year-ago quarter.

Total revenues for the quarter increased 2.0 percent to $397.82 million from $389.99 million in the same quarter last year. Organic revenue grew 4.8 percent.

Analysts expected the company to report earnings of $0.80 per share on revenues of $395.27 million for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Medical technology firm Integra LifeSciences Holdings Corp. (IART) announced Wednesday that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company, for $275 million in cash at closing. This is subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
RTTNews | Před 674 dny
Bay Street Headed For Weak Start

Bay Street Headed For Weak Start

Lower Canadian and U.S. futures amid worries about the health of US regional banks, and lingering concerns about U.S.-China trade tensions point to a weak start for the Canadian market on Friday.
RTTNews | Před 4 h 15 min
FTSE 100 Down 1.4%; Bank Stocks Fall On U.S. Lenders' Credit Woes

FTSE 100 Down 1.4%; Bank Stocks Fall On U.S. Lenders' Credit Woes

The UK market is down sharply on Friday, hurt by a sell-off in the financials sector amid concerns about the health of U.S. banks after a couple of regional banks disclosed that they were exposed to alleged fraud by borrowers, spreading jitters about credit market turmoil.
RTTNews | Před 5 h 35 min
Pound Falls Amid BoE Rate Cut Speculation

Pound Falls Amid BoE Rate Cut Speculation

The British pound weakened against other major currencies in the European session on Friday, amid rising expectations that the Bank of England (BoE) will cut interest rates further this year.
RTTNews | Před 6 h 15 min
Pound Falls Against Majors

Pound Falls Against Majors

The British pound weakened against other major currencies in the European session on Friday.
RTTNews | Před 6 h 38 min
DAX Down Over 2% As Credit Markets Worries Hurt Sentiment

DAX Down Over 2% As Credit Markets Worries Hurt Sentiment

Germany's DAX is down sharply on Friday with stocks tumbling amid concerns about the health of U.S. banking sector after Zions Bancorp and Western Alliance Bancorp disclosed on Thursday that they were exposed to alleged fraud by borrowers.
RTTNews | Před 7 h 5 min